The study focused on 9,848 GLP-1 prescriptions ordered between January 2018 and September 2022 for 6,094 patients who were enrolled either in Medicare or commercial insurance
N-acetylcysteine Pharmacology and Applications in Rare DiseasesRepurposing an Old Antioxidant
"One of the things that need improvement to the overall patient journey is trying to get as much information to patients as possible earlier in their journey, because it really does influence the path downstream," Reitano said
In September 2024, Terns Pharmaceuticals announced positive results from its Phase 1 clinical trial for TERN-601, a once-daily oral GLP-1 receptor agonist aimed at treating obesity
Remember that Mounjaro pens are single-use devices with a hidden, non-detachable needle
Updated practical management recommendations, with a specific focus on infantile-onset (Wolman) disease, have since been published by a Spanish expert panel, providing diagnostic algorithms for both phenotypes and updated treatment guidance (54)
